Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression
Authors:
- Xuesong LiXLXuesong Li
- Shuping XuSXShuping Xu
- Junkui AiJAJunkui Ai
- Yanqing GongYGYanqing Gong
- Jennifer L. GreggJGJennifer L. Gregg
- Ruili GuanRGRuili Guan
- Wei QiuWQWei Qiu
- Dianqi XinDXDianqi Xin
- Jeffrey R. GingrichJGJeffrey R. Gingrich
- Yinglu GuoYGYinglu Guo
- Guimin ChangGCGuimin Chang
- 1 June 2013
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 435 (4) , 526-532
Abstract
No abstract availableKeywords
Funding Information
- the China Health & Medical Development Foundation
This publication has 15 references indexed in Scilit:
- Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell linesBlood, 2011
- Cancer statistics, 2011CA: A Cancer Journal for Clinicians, 2011
- Hypoexpression and Epigenetic Regulation of Candidate Tumor Suppressor Gene CADM-2 in Human Prostate CancerClinical Cancer Research, 2010
- Whole-Genome Microarray Detects Deletions and Loss of Heterozygosity of Chromosome 3 Occurring Exclusively in Metastasizing Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2010
- A survey of therapy for advanced renal cell carcinomaUrologic Oncology: Seminars and Original Investigations, 2010
- Targeted therapies in metastatic renal cancer in 2009BJU International, 2009
- Characterization of the 3p12.3‐pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transferMolecular Carcinogenesis, 2009
- Cell adhesion and prostate tumor-suppressor activity of TSLL2/IGSF4C, an immunoglobulin superfamily molecule homologous to TSLC1/IGSF4Oncogene, 2005
- MethPrimer: designing primers for methylation PCRsBioinformatics, 2002
- TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancerNature Genetics, 2001